Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Boehringer Ingelheim
Merck
Fish and Richardson
Dow
Express Scripts
Chubb
Deloitte

Generated: May 22, 2018

DrugPatentWatch Database Preview

DOPAMINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Dopamine Hydrochloride patents expire, and when can generic versions of Dopamine Hydrochloride launch?

Dopamine Hydrochloride is a drug marketed by Abbott, Abraxis Pharm, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Luitpold, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun. and is included in thirty-six NDAs.

The generic ingredient in DOPAMINE HYDROCHLORIDE is dopamine hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
Summary for DOPAMINE HYDROCHLORIDE
Drug patent expirations by year for DOPAMINE HYDROCHLORIDE
Pharmacology for DOPAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DOPAMINE HYDROCHLORIDE

US Patents and Regulatory Information for DOPAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 019099-003 Oct 15, 1986 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teligent DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 018656-001 Jun 28, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 018826-003 Sep 30, 1983 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 019615-003 Mar 27, 1987 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Covington
Colorcon
Harvard Business School
Johnson and Johnson
US Department of Justice
AstraZeneca
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.